General Information
Otsuka MDD 263
Otsuka Pharmaceuticals, A Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy, Safety and Tolerability of an Oral (Aripiprazole/Escitalopram Combination Therapy in Patients With Major Depressive Disorder
| Protocol | 31-08-263 |
|---|---|
| Identifier | 31-08-263 |
| UID | 34be4bb6-f5f7-4f83-b69b-047e3ea415ac |
| Status | Done - Archived |
| Phase | 3 |
| Category | Major Depressive Disorder / Adult |
| Launch Year | 2010 |
| NCT Number | - |
| Created | 2010-08-02 15:12 |
| Last Updated | 2010-08-02 15:12 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2011-01-07 | No |
| Enrollment Open | 2010-10-04 | No |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2010-09-17 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2012-02-29 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Mohaupt, Stephen | SMohaupt | No |
| Recruiter | - | No | |
| Coordinator | Calleros, Jessica | JNCalleros | No |
| Regulatory | Aguirre, Sandra | SAguirre | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Otsuka Pharmaceuticals |
|---|---|
| Division | Otsuka Pharmaceuticals |
| Team | Otsuka Pharmaceuticals |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
